Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-12-075611
Filing Date
2012-11-08
Accepted
2012-11-08 07:00:42
Documents
10
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a12-20181_110q.htm 10-Q 912349
2 EX-31.1 a12-20181_1ex31d1.htm EX-31.1 11136
3 EX-31.2 a12-20181_1ex31d2.htm EX-31.2 11566
4 EX-32 a12-20181_1ex32.htm EX-32 7095
  Complete submission text file 0001104659-12-075611.txt   6328302

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT auxl-20120930.xml EX-101.INS 924394
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT auxl-20120930.xsd EX-101.SCH 40479
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT auxl-20120930_cal.xml EX-101.CAL 58924
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT auxl-20120930_def.xml EX-101.DEF 251497
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT auxl-20120930_lab.xml EX-101.LAB 727801
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT auxl-20120930_pre.xml EX-101.PRE 348511
Mailing Address 40 VALLEY STREAM PARKWAY MALVERN PA 19355
Business Address 40 VALLEY STREAM PARKWAY MALVERN PA 19355 484 321 5900
AUXILIUM PHARMACEUTICALS INC (Filer) CIK: 0001182129 (see all company filings)

EIN.: 233016883
Type: 10-Q | Act: 34 | File No.: 000-50855 | Film No.: 121188382
SIC: 2834 Pharmaceutical Preparations